Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions highlight various details from the publication, such as the role of the spike glycoprotein in binding to the ACE2 receptor, with phrases like 'knowledge is power' and expressions of excitement about its potential for vaccine development. The choice of words, such as 'superbly adapted' and references to comparative studies, indicate a mix of supportive enthusiasm and critical analysis among users, contributing to a lively exchange of ideas.
A majority of the posts express support for the article's findings, indicating a moderate level of collective agreement on its importance and relevance in understanding SARS-CoV-2.
The tone of the discussions reveals a strong curiosity about the spike glycoprotein and its implications, showcasing a high level of interest among the contributors.
Many posts engage deeply with the specifics of the research, with users referencing technical aspects of the spike glycoprotein structure and sharing related studies, demonstrating a thorough engagement with the material.
The perception of the article's impact is strong, with users believing the information has significant implications for vaccine development and understanding viral behavior.
Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is featured on the cover of @CellCellPress Cover art by @MelodyGCampbell https://t.co/WbDRmaM5zB https://t.co/KHZ4CWTG5z
A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao receptor ACE2. Ocorrida essa ligação, há uma "quebra" irreversível na conformação dessas subunidades e S2 promove a entrada na célula https://t.co/y50KyXI3hE https://t.co/PcYiOv77yE
@BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler published Mar 9 2020 (IKR) here: https://t.co/5pofdyAENN The BLASTp that you are seeing is that against HIV gp-41, which is the stalk of the HIV spike protein (yeah SC2 and https://t.co/XhN8tcyJM2
Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple coronaviruses. (Science is a powerful (and beautiful) thing!) Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/9A6OVc8SEz
A journal cover for the history books ⬇️ My colleague @coronalexington, together with @YoungjunPark11, solved the SARS2 spike by Cryo-EM, mapped it's interaction w ACE2, and got a head-start on the race for protective antibodies. @veeslerlab
3 year Delta - https://t.co/YCh6zO3Q2i https://t.co/y1u2kUFVAc Knowledge is power. https://t.co/RZBiXo9zl5
Since its emergence in December 2019, the world has been dealing with COVID-19, officially declared a pandemic by the WHO. This video explores Remdesivir, the first FDA-approved antiviral for COVID-19, detailing its…
Welcome to 15 meters of Knowledge. This video presents information on SARS-CoV-2 and the vaccines designed to combat it. The spike glycoprotein plays a critical role in viral entry into human cells, making it essential…
In this video, Claudia explains how vaccines against Covid-19 work, including the role of the SARS-CoV-2 spike glycoprotein in cell entry. She also outlines the differences between various vaccines, drawing on…
@tommy_cleary @billwilliam321 @BillyBostickson Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Pick a date..... https://t.co/V2QiQWPcxz https://t.co/Bi9Zi8ypiM
RT @kobomasa4721: Q4114 e 2020年05月05日 https://t.co/nqE4oTZZ5Z https://t.co/OauBWf59IF SARS-CoV-2の受容体結合部位のタンパク質配列を解析したところ、興味深い結果が得られた。SARS-C…
RT @WeAreWoke1776_3:
RT @WeAreWoke1776_3:
RT @WeAreWoke1776_3:
RT @kobomasa4721: Q4114 e 2020年05月05日 https://t.co/nqE4oTZZ5Z https://t.co/OauBWf59IF SARS-CoV-2の受容体結合部位のタンパク質配列を解析したところ、興味深い結果が得られた。SARS-C…
@denniksme https://t.co/9IoHUiyLaT
@KolikovaMaria https://t.co/9IoHUiyLaT
@M_Holeckova https://t.co/9IoHUiyLaT
@ZolkoMeme https://t.co/9IoHUiyLaT
@MO_europe @danielpetrula @denniksme https://t.co/9IoHUizj0r
@Nefilim9 https://t.co/9IoHUizj0r
@M_Holeckova https://t.co/9IoHUizj0r
@Aktualitysk https://t.co/9IoHUizj0r
@licioppelin https://t.co/9IoHUiyLaT
@gl_sk https://t.co/9IoHUizj0r
@gl_sk https://t.co/9IoHUizj0r
@sandoly @MidwesternDoc Imaging: Walls AC, Park YJ, Tortorici MA, et al. (2020). "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein." Cell, 181(2), 281-292.e6. DOI: 10.1016/j.cell.2020.02.058
@gl_sk https://t.co/9IoHUizj0r
@CT24zive @MilanMikula8 https://t.co/9IoHUizj0r
@r_choleva https://t.co/9IoHUizj0r
@MSimecka @drdavidmartin https://t.co/9IoHUiyLaT
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells https://t.co/RaSMVSuhK4 Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/kSru2kCqTe https://t.co/xtK4pckarv
The phrase ‘superbly adapted to human ACE2’ misleading. All it had to do was bind. Even an average KD should have been enough to enter cells. Early papers (eg April 2020 by a top team) suggested wt #SARSCoV2 affinity not much different from #SARSCoV https://t.co/pFvjljd5Zj https://t.co/FGcv8wudAA
"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" https://t.co/0yMUaF5MlR
RT @KimWever3: 4 year Delta- https://t.co/npHDEBqosq https://t.co/YCh6zO3Q2i ... https://t.co/y1u2kUFVAc Both SARS-CoV-2 and SARS-CoV use t…
RT @KimWever3: 4 year Delta- https://t.co/npHDEBqosq https://t.co/YCh6zO3Q2i ... https://t.co/y1u2kUFVAc Both SARS-CoV-2 and SARS-CoV use t…
4 year Delta- https://t.co/npHDEBqosq https://t.co/YCh6zO3Q2i ... https://t.co/y1u2kUFVAc Both SARS-CoV-2 and SARS-CoV use the same host cell receptor. Knowledge is power. https://t.co/dMsCPCMQPk
RT @kobomasa4721: Q4114 e 2020年05月05日 https://t.co/nqE4oTZZ5Z https://t.co/OauBWf59IF SARS-CoV-2の受容体結合部位のタンパク質配列を解析したところ、興味深い結果が得られた。SARS-C…
RT @kobomasa4721: Q4114 e 2020年05月05日 https://t.co/nqE4oTZZ5Z https://t.co/OauBWf59IF SARS-CoV-2の受容体結合部位のタンパク質配列を解析したところ、興味深い結果が得られた。SARS-C…
@ShadowofEzra The ad on his page had 41 k views..I sought 1610 but nothing so I made it 1611 Got - they are fighting for their lives Good people in place Follow the family Also nih re covid links https://t.co/kOBFQAXICm https://t.co/Agr1qSKOwm https://t.co/c1dFtJs1r8 Knowledge is power https://t.co/TL6hhtI3WF
@DanScavino Q4114 https://t.co/GkOdQe5hbj https://t.co/aYO4MVs0tf When the protein sequence of the SARS-CoV-2 receptor binding site was analyzed, an interesting result was found. https://t.co/y5GdsXduTu Knowledge is power. Q https://t.co/qVpmaHtf3k
@WeAreWoke1776_3 @doqholliday https://t.co/y5GdsXduTu Both SARS-CoV-2 and SARS-CoV use the same host cell receptor. It also found that, for both viruses, the viral proteins used for host cell entry bind to the receptor with the same tightness (affinity). Knowledge is power. Q https://t.co/wt2tkLyaVN
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
RT @Jikkyleaks: @BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler p…
@BlackTomThePyr8 OK Tom here you go. The 6VXX version there is a pseudovirus of SARS-Cov-2 created by Walls and Veesler published Mar 9 2020 (IKR) here: https://t.co/5pofdyAENN The BLASTp that you are seeing is that against HIV gp-41, which is the stalk of the HIV spike protein (yeah SC2 and https://t.co/XhN8tcyJM2
RT @DocRock1007: 55. "Both SARS-CoVs enter the cell via the angiotensin-converting enzyme 2 (ACE2) receptor." "It also found that, for bo…
RT @KimWever3: 3 year Delta - https://t.co/YCh6zO3Q2i https://t.co/y1u2kUFVAc Knowledge is power. https://t.co/RZBiXo9zl5
RT @KimWever3: 3 year Delta - https://t.co/YCh6zO3Q2i https://t.co/y1u2kUFVAc Knowledge is power. https://t.co/RZBiXo9zl5
RT @KimWever3: 3 year Delta - https://t.co/YCh6zO3Q2i https://t.co/y1u2kUFVAc Knowledge is power. https://t.co/RZBiXo9zl5
RT @KimWever3: 3 year Delta - https://t.co/YCh6zO3Q2i https://t.co/y1u2kUFVAc Knowledge is power. https://t.co/RZBiXo9zl5
3 year Delta - https://t.co/YCh6zO3Q2i https://t.co/y1u2kUFVAc Knowledge is power. https://t.co/RZBiXo9zl5
RT @kobomasa4721: Q4114 e 2020年05月05日 https://t.co/nqE4oTZZ5Z https://t.co/OauBWf59IF SARS-CoV-2の受容体結合部位のタンパク質配列を解析したところ、興味深い結果が得られた。SARS-C…
Q4114 e 2020年05月05日 https://t.co/nqE4oTZZ5Z https://t.co/OauBWf59IF SARS-CoV-2の受容体結合部位のタンパク質配列を解析したところ、興味深い結果が得られた。SARS-CoV-2は全体的にコウモリコロナウイルスと似ているが、受容体結合部位はSARS-CoVとより似ていた。 https://t.co/8B5KQePnGe
@omegamillennial @BenFreeman2225 @stillgray Read, understand. It will take you several hours to get through all of the sourced material. Come back to me and apologize for being wrong the entire time. https://t.co/WntfHQNZg0
@leelasik @TOPDOGE007 @nelsonepega ACE2 https://t.co/WntfHQNZg0 https://t.co/yJyRxuHhR0
@mlperk1 Correction Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/pWmXM5RPbG
Two Researchers pose on the cover of Cell journal for their latest paper, "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" https://t.co/iJwMPN1URy
@Litercurious1 https://t.co/GtVQBLrhQt Sturucture, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexander C. Walls et al. DOI: https://t.co/B8K6T5Vhqw https://t.co/CNZufZ7sa5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 30 https://t.co/lpHrNwPe6z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 29 https://t.co/KQSR8sdi5Y
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 28 https://t.co/uRpEQGxleA
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 27 https://t.co/D4Fa4pO9xN
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 26 https://t.co/PyiUQkjBc5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 25 https://t.co/nl4Z1rWctV
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 24 https://t.co/w3avPB2RHZ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 23 https://t.co/OEuIe04Zb1
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 22 https://t.co/CFXLZNSHAK
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 21 https://t.co/9EjhUIXawJ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 20 https://t.co/cJXqQykeQc
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 19 https://t.co/AesqGP4U6l
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 18 https://t.co/wttIkNClPe
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 17 https://t.co/3r7lvRMQee
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 16 https://t.co/2cLj60d2Im
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 15 https://t.co/9bDlqHtD5z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 13 https://t.co/w3EvYVb9t5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 12 https://t.co/ibvvBHLJGy
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 11 https://t.co/3YEI30ykuy
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 30 https://t.co/lpHrNwPe6z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 29 https://t.co/KQSR8sdi5Y
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 28 https://t.co/uRpEQGxleA
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 27 https://t.co/D4Fa4pO9xN
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 26 https://t.co/PyiUQkjBc5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 25 https://t.co/nl4Z1rWctV
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 24 https://t.co/w3avPB2RHZ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 23 https://t.co/OEuIe04Zb1
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 22 https://t.co/CFXLZNSHAK
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 21 https://t.co/9EjhUIXawJ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 20 https://t.co/cJXqQykeQc
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 19 https://t.co/AesqGP4U6l
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 18 https://t.co/wttIkNClPe
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 17 https://t.co/3r7lvRMQee
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 16 https://t.co/2cLj60d2Im
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 15 https://t.co/9bDlqHtD5z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 14 https://t.co/OHVCx1ZDwF
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 13 https://t.co/w3EvYVb9t5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 12 https://t.co/ibvvBHLJGy
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 11 https://t.co/3YEI30ykuy
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 30 https://t.co/lpHrNwPe6z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 29 https://t.co/KQSR8sdi5Y
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 28 https://t.co/uRpEQGxleA
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 27 https://t.co/D4Fa4pO9xN
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 26 https://t.co/PyiUQkjBc5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 25 https://t.co/nl4Z1rWctV
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 24 https://t.co/w3avPB2RHZ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 23 https://t.co/OEuIe04Zb1
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 22 https://t.co/CFXLZNSHAK
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 21 https://t.co/9EjhUIXawJ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 20 https://t.co/cJXqQykeQc
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 19 https://t.co/AesqGP4U6l
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 18 https://t.co/wttIkNClPe
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 17 https://t.co/3r7lvRMQee
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 16 https://t.co/2cLj60d2Im
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 15 https://t.co/9bDlqHtD5z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 14 https://t.co/OHVCx1ZDwF
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 13 https://t.co/w3EvYVb9t5
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 12 https://t.co/ibvvBHLJGy
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 11 https://t.co/3YEI30ykuy
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 11 https://t.co/3YEI30ykuy
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 12 https://t.co/ibvvBHLJGy
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 13 https://t.co/w3EvYVb9t5
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 14 https://t.co/OHVCx1ZDwF
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 15 https://t.co/9bDlqHtD5z
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 16 https://t.co/2cLj60d2Im
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 17 https://t.co/3r7lvRMQee
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 18 https://t.co/wttIkNClPe
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 19 https://t.co/AesqGP4U6l
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 20 https://t.co/cJXqQykeQc
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 21 https://t.co/9EjhUIXawJ
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 22 https://t.co/CFXLZNSHAK
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 23 https://t.co/OEuIe04Zb1
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 24 https://t.co/w3avPB2RHZ
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 25 https://t.co/nl4Z1rWctV
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 26 https://t.co/PyiUQkjBc5
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 27 https://t.co/D4Fa4pO9xN
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 28 https://t.co/uRpEQGxleA
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 29 https://t.co/KQSR8sdi5Y
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 30 https://t.co/lpHrNwPe6z
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 58 https://t.co/u94aeiFw6L
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 57 https://t.co/hZzW8p3O5i
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 56 https://t.co/KyfHDQMSQQ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 55 https://t.co/R7N6BDk1x3
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 54 https://t.co/juo4lPoXdx
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 53 https://t.co/BPv1S9SJz0
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 52 https://t.co/RVfh9p9gzz
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 51 https://t.co/FRCSVW2nnX
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 50 https://t.co/iIIupjL7f7
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 49 https://t.co/ffIY6lc8lz
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 47 https://t.co/pOfkgBt9Ve
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 45 https://t.co/7evEGmJtbQ
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 44 https://t.co/Q6cqNg7VYg
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 43 https://t.co/mSMyjxxtue
RT @ezzyku: Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein part 42 https://t.co/Wd6JeIDcXW
RT @QuantumMed3: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (3/4) https://t.co/5uBAF0kepG For more inform…
RT @PossDoug: https://t.co/Gm48AO5jyw
https://t.co/Gm48AO5jyw
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (3/4) https://t.co/5uBAF0kepG For more information watch this YouTube video. https://t.co/bjmnYirTOZ
@evanhowington @RavenRickGrime1 Absolutely: (read please!) https://t.co/C334SyBoCD https://t.co/nPBUZ7wlDi
RT @SpicyNFTs: @InUtahNotOfUtah I guess you missed how the military knew at the beginning of the pandemic that hydroxychloroquine and Iverm…
@InUtahNotOfUtah I guess you missed how the military knew at the beginning of the pandemic that hydroxychloroquine and Ivermectin were curative. You should have listened to us. https://t.co/C334SyBoCD https://t.co/nPBUZ7wlDi https://t.co/eoUnmuQUGs
@Michael_Rogo @MikeSington Yup! https://t.co/nPBUZ7wlDi https://t.co/iWta9duMb1
@MattWhitaker46 https://t.co/Agr1qT1Rym https://t.co/c1dFtJJ4t8 Both SARS-CoV-2 and SARS-CoV use the same host cell receptor. It also found that, for both viruses, the viral proteins used for host cell entry bind to the receptor with the same tightness (affinity). Knowledge is power.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/qmNocgiYVz
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/BcMHl1CR3O
@FThooligan HCQ for the win! https://t.co/C334SyBoCD https://t.co/nPBUZ7wlDi https://t.co/t9508zhxgA
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/GtI1nL1vKB
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/aJYQRdftwn
@ale_battini @sense_strand @rapidgator99 @Chris_F_Carson @ChrisMasseyFOIs @TomahawkVPhD @DanitaDay19 @moravec_tomas @JavRoJav @NorthernMarlin @Alex_on_A14 @Corax_The_Raven Hey, hello, over here, things you’re ignoring. https://t.co/d5yyNXdpUV
@ale_battini @sense_strand @rapidgator99 @Chris_F_Carson @ChrisMasseyFOIs @TomahawkVPhD @DanitaDay19 @moravec_tomas @JavRoJav @NorthernMarlin @Alex_on_A14 @Corax_The_Raven Here’s another paper that did extensive characterization of the same structure, which is the spike protein belonging to SCV2. https://t.co/d5yyNXdpUV
@Betsabe20036478 @_Elinvestigador @JoseBogas1 Lo tuyo es pura palabrería sin fundamento. E aquí algunos estudios científicos. https://t.co/vbZhbzb25v https://t.co/CDd8QG8jVf https://t.co/O1dM7Y4O5c https://t.co/h7KQT4e8UM https://t.co/NbTrOgHzC1 https://t.co/fdLlvQmBc8 https://t.co/YLaRsOfbkO https://t.co/0oelMPLA5t
https://t.co/5hlq7mZz2o Both SARS-CoV-2 and SARS-CoV use the same host cell receptor. It also found that, for both viruses, the viral proteins used for host cell entry bind to the receptor with the same tightness (affinity). Knowledge is power.
https://t.co/kmUtXFbtKd
@johanhofman binding met ACE2 receptor: https://t.co/rMZmyq1Nj2 zoals ook al in maart vastgesteld: https://t.co/7pMZpxGXu6
@EpigeneticWhisp Cell journal study: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/nRawZvP2vG
@muchojordan @drsimonegold 2) The CDC who’s been caught lying and fudging the entire pandemic. https://t.co/Bi504m0G6C
Cell journal study: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/nRawZvP2vG
@NickLiotta5 @thejtlewis @GeneralDilley https://t.co/IVpjcbwNl2 Both SARS-CoV-2 and SARS-CoV use the same host cell receptor. It also found that, for both viruses, the viral proteins used for host cell entry bind to the receptor with the same tightness (affinity).
RT @HirofumiSeo: スパイク先端は、本当はopen / closed stateが平衡状態で、全てのスパイクで先端がカチャカチャ動いていると思うのですが、CGが重くなりすぎてしまうため説明時以外は全部止まっています。ごめんなさい。ちなみに https://t.co…
RT @HirofumiSeo: スパイク先端は、本当はopen / closed stateが平衡状態で、全てのスパイクで先端がカチャカチャ動いていると思うのですが、CGが重くなりすぎてしまうため説明時以外は全部止まっています。ごめんなさい。ちなみに https://t.co…
RT @HirofumiSeo: スパイク先端は、本当はopen / closed stateが平衡状態で、全てのスパイクで先端がカチャカチャ動いていると思うのですが、CGが重くなりすぎてしまうため説明時以外は全部止まっています。ごめんなさい。ちなみに https://t.co…
スパイク先端は、本当はopen / closed stateが平衡状態で、全てのスパイクで先端がカチャカチャ動いていると思うのですが、CGが重くなりすぎてしまうため説明時以外は全部止まっています。ごめんなさい。ちなみに https://t.co/A8kJGEAjLT によると、開くのは常に1個だけのようです。 #BS1スペシャル
I can't find much consistency in what researchers say now about the extra PRRA seq. This article https://t.co/JB5xXkYxoQ leads to https://t.co/Oj3cSCn6jh
RT @EricBillyFR: @DocGSYJ @EvidenceStudio @BioHospitalix @Macronade3 @apyretyque @Antibiogramme Timings de la réponse immunitaire sur kit I…
@DocGSYJ @EvidenceStudio @BioHospitalix @Macronade3 @apyretyque @Antibiogramme Timings de la réponse immunitaire sur kit IP: https://t.co/eewHFM6z4D Une partie de la réponse ici https://t.co/Fro4S06lF9 https://t.co/eWBfA4h8z8 Il manque une publication dont j’avais parlé > un mois. Équipe de HK et IP montrant la cinétique d’apparition antiN et anti S
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
RT @JamesEKHildreth: Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple c…
Truly exciting science published in top journal indicates a vaccine might be possible that protects against multiple coronaviruses. (Science is a powerful (and beautiful) thing!) Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein https://t.co/9A6OVc8SEz
Structure, Function, and Antigenicity of the SARSCoV-2 Spike Glycoprotein https://t.co/dB32XoObw8 #CoV2 #diagnostics #labmedicine #covid19 #veravas
RT @Thrashton57: @OutlawedPhenom Here is more on how the new Coronavirus relates in structure to the SARS-Cov virus that was successfully p…
@CaprisunKev https://t.co/IVpjcbwNl2 Both SARS-CoV-2 and SARS-CoV use the same host cell receptor. It also found that, for both viruses, the viral proteins used for host cell entry bind to the receptor with the same tightness (affinity).
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
@OutlawedPhenom Here is more on how the new Coronavirus relates in structure to the SARS-Cov virus that was successfully prevented and treated with HCQ years ago. https://t.co/TXEoQEI74p
RT @ARIEyan35239829: Original source: https://t.co/rzy2dXgwSp https://t.co/tU3keDOizu https://t.co/Vu06vuvlV7 https://t.co/ahequKrrT5 ht…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @ichaydon: A journal cover for the history books ⬇️ My colleague @coronalexington, together with @YoungjunPark11, solved the SARS2 spik…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
RT @mab_sp125: A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao rec…
A proteína S tem duas subunidades (S1 e S2) de interação dinâmica. Em S1 está a região (RBD) responsável por se ligar ao receptor ACE2. Ocorrida essa ligação, há uma "quebra" irreversível na conformação dessas subunidades e S2 promove a entrada na célula https://t.co/y50KyXI3hE https://t.co/PcYiOv77yE
@theamandaread @GMWatch Scores, probably hundreds of them. Here is just one of the papers: https://t.co/4ApARvVlBd
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @ichaydon: A journal cover for the history books ⬇️ My colleague @coronalexington, together with @YoungjunPark11, solved the SARS2 spik…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @ichaydon: A journal cover for the history books ⬇️ My colleague @coronalexington, together with @YoungjunPark11, solved the SARS2 spik…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @ichaydon: A journal cover for the history books ⬇️ My colleague @coronalexington, together with @YoungjunPark11, solved the SARS2 spik…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
https://t.co/jhCeTpu0z0 Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein by Alexandra et Walls Young-Jun Park M. Alejandra Tortorici Abigail Wall Andrew McGuire David Veesler #COVID19
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
A journal cover for the history books ⬇️ My colleague @coronalexington, together with @YoungjunPark11, solved the SARS2 spike by Cryo-EM, mapped it's interaction w ACE2, and got a head-start on the race for protective antibodies. @veeslerlab
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
RT @veeslerlab: Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is…
Really excited that our article describing the structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein is featured on the cover of @CellCellPress Cover art by @MelodyGCampbell https://t.co/WbDRmaM5zB https://t.co/KHZ4CWTG5z
RT @IdiUcv: Estructura, función y antigenicidad de la glicoproteína de la punta del SARS-CoV-2. https://t.co/g95LXom7H9 https://t.co/3dG2FI…
RT @IdiUcv: Estructura, función y antigenicidad de la glicoproteína de la punta del SARS-CoV-2. https://t.co/g95LXom7H9 https://t.co/3dG2FI…
RT @IdiUcv: Estructura, función y antigenicidad de la glicoproteína de la punta del SARS-CoV-2. https://t.co/g95LXom7H9 https://t.co/3dG2FI…
Estructura, función y antigenicidad de la glicoproteína de la punta del SARS-CoV-2. https://t.co/g95LXom7H9 https://t.co/3dG2FIx5Ny
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike slycoprotein. Cell. 2020 Mar 6. pii: S0092-8674(20)30262-2. doi: 10.1016/j.cell.2020.02.058. [Epub ahead of print]…https://t.co/XEJe0JR6gT
RT @ZhouLabUCR: There is "an unexpected furin cleavage site at the S1/S2 boundary of SARS-CoV-2 S, which is cleaved during biosynthesis-a n…
RT @ZhouLabUCR: There is "an unexpected furin cleavage site at the S1/S2 boundary of SARS-CoV-2 S, which is cleaved during biosynthesis-a n…
RT @ZhouLabUCR: There is "an unexpected furin cleavage site at the S1/S2 boundary of SARS-CoV-2 S, which is cleaved during biosynthesis-a n…
RT @ZhouLabUCR: There is "an unexpected furin cleavage site at the S1/S2 boundary of SARS-CoV-2 S, which is cleaved during biosynthesis-a n…
#MCB2020F #MCBTeaching Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein | @scoopit
RT @Ezgi_Karaca_: @bariskomur @uosseker @CagatayTarhan Uygun deney yöntemlerini şu makaleden inceleyebilirsiniz: https://t.co/dmMyw42aDv
RT @Ezgi_Karaca_: @bariskomur @uosseker @CagatayTarhan Uygun deney yöntemlerini şu makaleden inceleyebilirsiniz: https://t.co/dmMyw42aDv
@bariskomur @uosseker @CagatayTarhan Uygun deney yöntemlerini şu makaleden inceleyebilirsiniz: https://t.co/dmMyw42aDv
@RommieAmaro @LCasalino88 @zied_gaieb @abbydommer @AmaroLab Hi, I wonder about the cleaved position R685-S686 typical for S1/S2 in the all-atom MD simulation. Should the simulation account for this effect? Note that it was found to be present since the viral synthesis https://t.co/l8fPPZjttG
RT @JohnBeachTX: @SadiRazaMD @HeartOTXHeartMD Interesting that BNP is elevated in COVID19. Is this because the SARS-CoV-2 virus stimulates…
@SadiRazaMD @HeartOTXHeartMD Interesting that BNP is elevated in COVID19. Is this because the SARS-CoV-2 virus stimulates increased production of furin for its own cleavage purposes, & the elevated BNP is a side-effect of the increased presence of furin? https://t.co/OV9h9CwPWD https://t.co/mWV4ObScfj
@EricTopol @jclinicalinvest @ACasadevall1 @JohnsHopkinsSPH @EinsteinMed ... SARS-CoV S mouse polyclonal sera potently inhibited entry into target cells of SARS-CoV-2 S pseudotyped viruses ... Cell 03-09 https://t.co/BAwFWg3Rpu ... sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry ... Cell 03-05 https://t.co/akSWK6AsJR
@mikemoevolution @gianlucac1 Bella domanda. https://t.co/JBW3YIG8mv